SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-24-000144
Filing Date
2024-01-11
Accepted
2024-01-11 16:56:00
Documents
13
Period of Report
2024-01-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fussbrands_8k.htm   iXBRL 8-K 36231
2 EXHIBIT 99.1 fussbrands_ex99-1.htm EX-99.1 7735
  Complete submission text file 0001829126-24-000144.txt   213700

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE fbds-20240110.xsd EX-101.SCH 3018
4 XBRL LABEL FILE fbds-20240110_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE fbds-20240110_pre.xml EX-101.PRE 22361
7 EXTRACTED XBRL INSTANCE DOCUMENT fussbrands_8k_htm.xml XML 3034
Mailing Address 80 BROAD STREET 5TH FLOOR NEW YORK NY 10004
Business Address 80 BROAD STREET 5TH FLOOR NEW YORK NY 10004 917-720-3366
Fuss Brands Corp. (Filer) CIK: 0000926844 (see all company filings)

IRS No.: 841273503 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-34808 | Film No.: 24529815
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)